Similarly, TGF-β was significantly higher in severe COVID-19 patients than healthy subjects (19,811 ± 2632 vs 8274 ± 1790 pg/mL, p = 0.003, t-test), despite no significance in the ANOVA test. This evidence concerns the gene TGFB1 and COVID-19.